Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
First Claim
1. A diagnostic kit for detecting an antibody which specifically recognizes Lelystad Agent in a biological sample, said diagnostic kit comprisingan antigen selected from the group consisting of virus, protein, polypeptide, and peptide, said antigen immunoreactive with serum antibodies of a sow, said serum antibodies obtained by:
- a) intranasally inoculating a specific pathogen free sow with two milliliters of a virus essentially corresponding to the virus identified as deposit number I-1102, deposited Jun. 5, 1991 with the Institut Pasteur, Paris, France (at passage level 3, titer 104.8 TCID50/milliliter); and
further comprising b) collecting serum antibodies from the thus inoculated sow after 25 to 33 days, and means for detecting an antibody.
3 Assignments
0 Petitions
Accused Products
Abstract
Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
48 Citations
3 Claims
-
1. A diagnostic kit for detecting an antibody which specifically recognizes Lelystad Agent in a biological sample, said diagnostic kit comprising
an antigen selected from the group consisting of virus, protein, polypeptide, and peptide, said antigen immunoreactive with serum antibodies of a sow, said serum antibodies obtained by: -
a) intranasally inoculating a specific pathogen free sow with two milliliters of a virus essentially corresponding to the virus identified as deposit number I-1102, deposited Jun. 5, 1991 with the Institut Pasteur, Paris, France (at passage level 3, titer 104.8 TCID50/milliliter); and
further comprisingb) collecting serum antibodies from the thus inoculated sow after 25 to 33 days, and means for detecting an antibody. - View Dependent Claims (3)
-
-
2. A diagnostic kit for detecting an antibody which specifically recognizes Lelystad Agent in a biological sample said Lelystad Agent essentially corresponding to the isolated Lelystad Agent deposited 5 Jun. 1991 with the Institut Pasteur, Paris, France, deposit number I-1102, said diagnostic kit comprising:
-
a protein or antigenic polypeptide from Lelystad Agent, and means for detecting an antibody reacting with said protein or antigenic polypeptide.
-
Specification